Inter-reader Agreement of F-FDG PET/CT for the Quantification of Carotid Artery Plaque Inflammation

Overview

Journal JRSM Cardiovasc Dis

Specialty Cardiology & Vascular Diseases

Date 2021 Jan 6

PMID 33403110

Citations 2

Authors

Kjersti Johnsrud

Therese Seierstad

David Russell

Mona-Elisabeth Revheim

Affiliations

Soon will be listed here.

Abstract

Introduction: A significant proportion of ischemic strokes are caused by emboli from unstable atherosclerotic carotid artery plaques. Inflammation is a key feature of plaque instability. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-(F)-fluoro-D-glucose (F-FDG) is a promising technique to quantify plaque inflammation, but a consensus on the methodology has not been established. High inter-reader agreement is essential if F-FDG PET/CT is to be used as a clinical tool for the assessment of unstable plaques and stroke risk.

Methods: We assessed the inter-reader variability of different methods for quantification of F-FDG uptake in 43 patients with carotid artery stenosis ≥70%. Two independent readers delineated the plaque and collected maximum standardized uptake value (SUV) from all axial PET slices containing the atherosclerotic plaque.

Results: Uptake values with and without background correction were calculated and intraclass correlation coefficients were highest for uncorrected uptake values (0.97-0.98) followed by those background corrected by subtraction (0.89-0.94) and lowest for those background corrected by division (0.74-0.79).

Conclusion: Quantification methods without background correction have the highest inter-reader agreement for F-FDG PET of carotid artery plaque inflammation. The use of the single highest uptake value (max SUV) from the plaque will facilitate the method's clinical utility in stroke prevention.

Citing Articles

Bilateral Carotid Artery Molecular Calcification Assessed by [F] Fluoride PET/CT: Correlation with Cardiovascular and Thromboembolic Risk Factors.

Patil S, Teichner E, Subtirelu R, Parikh C, Al-Daoud O, Ismoilov M Life (Basel). 2023; 13(10).

PMID: 37895451 PMC: 10608649. DOI: 10.3390/life13102070.

Stroke and molecular imaging: a focus on FDG-PET.

Ayubcha C, Amanullah A, Patel K, Teichner E, Gokhale S, Marquez-Valenzuela U Am J Nucl Med Mol Imaging. 2023; 13(2):51-63.

PMID: 37214267 PMC: 10193198.

References

Rudd J, Myers K, Bansilal S, Machac J, Pinto C, Tong C . Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008; 49(6):871-8. DOI: 10.2967/jnumed.107.050294. View

Tarkin J, Joshi F, Evans N, Chowdhury M, Figg N, Shah A . Detection of Atherosclerotic Inflammation by Ga-DOTATATE PET Compared to [F]FDG PET Imaging. J Am Coll Cardiol. 2017; 69(14):1774-1791. PMC: 5381358. DOI: 10.1016/j.jacc.2017.01.060. View

Marnane M, Merwick A, Sheehan O, Hannon N, Foran P, Grant T . Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012; 71(5):709-18. DOI: 10.1002/ana.23553. View

Rudd J, Myers K, Bansilal S, Machac J, Rafique A, Farkouh M . (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007; 50(9):892-6. DOI: 10.1016/j.jacc.2007.05.024. View

Muller H, Viaccoz A, Fisch L, Bonvin C, Lovblad K, Ratib O . 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals. Stroke. 2014; 45(12):3561-6. DOI: 10.1161/STROKEAHA.114.006488. View

Kwee R, Truijman M, Mess W, Teule G, ter Berg J, Franke C . Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques. AJNR Am J Neuroradiol. 2011; 32(5):950-4. PMC: 7965558. DOI: 10.3174/ajnr.A2381. View

Chowdhury M, Tarkin J, Evans N, Le E, Warburton E, Hayes P . F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis. Eur J Vasc Endovasc Surg. 2018; 56(2):172-179. PMC: 6105570. DOI: 10.1016/j.ejvs.2018.03.028. View

Grant E, Benson C, Moneta G, Alexandrov A, Baker J, Bluth E . Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003; 229(2):340-6. DOI: 10.1148/radiol.2292030516. View

Huet P, Burg S, Le Guludec D, Hyafil F, Buvat I . Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. J Nucl Med. 2015; 56(4):552-9. DOI: 10.2967/jnumed.114.142596. View

10.

Graebe M, Borgwardt L, Hojgaard L, Sillesen H, Kjaer A . When to image carotid plaque inflammation with FDG PET/CT. Nucl Med Commun. 2010; 31(9):773-9. DOI: 10.1097/MNM.0b013e32833c365e. View

11.

. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998; 351(9113):1379-87. View

12.

Bucerius J, Hyafil F, Verberne H, Slart R, Lindner O, Sciagra R . Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis. Eur J Nucl Med Mol Imaging. 2015; 43(4):780-92. PMC: 4764627. DOI: 10.1007/s00259-015-3259-3. View

13.

Boellaard R, Delgado-Bolton R, Oyen W, Giammarile F, Tatsch K, Eschner W . FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2014; 42(2):328-54. PMC: 4315529. DOI: 10.1007/s00259-014-2961-x. View

14.

Skagen K, Johnsrud K, Evensen K, Scott H, Krohg-Sorensen K, Reier-Nilsen F . Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients. Int J Stroke. 2015; 10(5):730-6. DOI: 10.1111/ijs.12430. View

15.

Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim M . F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques. J Nucl Cardiol. 2017; 26(3):883-893. PMC: 6517604. DOI: 10.1007/s12350-017-1121-7. View

16.

Barnett H, Taylor D, Eliasziw M, Fox A, Ferguson G, Haynes R . Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339(20):1415-25. DOI: 10.1056/NEJM199811123392002. View

17.

Jander S, Sitzer M, Schumann R, Schroeter M, Siebler M, Steinmetz H . Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke. 1998; 29(8):1625-30. DOI: 10.1161/01.str.29.8.1625. View

18.

Stoll G, Bendszus M . Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006; 37(7):1923-32. DOI: 10.1161/01.STR.0000226901.34927.10. View

19.

Gasecki A, Eliasziw M, Ferguson G, Hachinski V, Barnett H . Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. J Neurosurg. 1995; 83(5):778-82. DOI: 10.3171/jns.1995.83.5.0778. View

20.

Libby P . Inflammation in atherosclerosis. Nature. 2002; 420(6917):868-74. DOI: 10.1038/nature01323. View